Utilizing Facility Data for Program Monitoring Valerie Koscelnik Track 1 ART Program Meeting Maputo, August 12, 2010.

Slides:



Advertisements
Similar presentations
ICAP-Columbia University Track 1.0 Program (MCAP) Track 1.0 Meeting - Maputo August 2010.
Advertisements

Follow-up after training and supportive supervision The IMAI District Coordinator Course.
CDC Mozambique Transition Monitoring Approach 8 th Annual Track 1 meeting, August 12, 2010 Charity Alfredo CDC-Mozambique.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
The District Mentorship Initiative in Tanzania Track 1.0 Annual Meeting Redempta Mbatia ICAP Tanzania August 10 th 2010.
John Aberle-Grasse CDC GAP Strategies for Building National-Scale Longitudinal Patient Monitoring Systems for HIV Treatment and Care Lusaka, October 2-5,
Evaluating ICAP-supported Prevention of Mother to Child Transmission (PMTCT) Programs in 7 countries: Rosalind Carter, PhD Epidemiologist, PMTCT, Pediatrics.
Prevention of Mother-to-Child Transmission of HIV in Ghana
Bobby Jefferson Senior HMIS Advisor Futures Group The Site Capacity Assessment (SCA) Tool and other Mechanisms to Monitor Transition Status Track 1 Implementers.
Cross-cutting Capacity Building Needs of Proposed Local Partners Philippe Chiliade, MD,MHA HHS / HRSA Maputo, Mozambique August 12, 2010.
Module 2: Basic analyses. Module 2: Learning Objectives  Identify approaches for setting targets  Understand common analyses that calculate program.
“Getting to Zero: Thailand’s Experience with E-MTCT” Petchsri Sirinirund Advisor on HIV/AIDS Policy and Programme Department of Disease Control, Thailand.
Orientation to data collection processes and inaugural quarterly discussion of latest data on ICAP programs MER April ICAP quarterly data meeting.
ICAP Tanzania’s Experiences Implementing an Aggregate Database: District Health Information System (DHIS) Joshua Chale, Data Manager July 28, 2010.
Reproductive Health Needs of Men and Women Enrolled in HIV Care and Treatment Services Elaine Abrams August 12, 2008 Track 1.0 Meeting.
Assessing & Improving Quality of Care Newly Developed Quality of Care Tools President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting Seema.
The President’s Emergency Plan for AIDS Relief Next Generation Indicators.
AIDS Prevention Initiative Nigeria Monitoring and Evaluation in the Transition Toyin Jolayemi – APIN Ltd Seema Meloni - Harvard.
ICAP HIV Testing and Counseling indicators Initial summary of data, January-March 2010 quarter ICAP.
FHI’s Global ART Program: Today's snapshot and tomorrow's vision 10 August 2010 Kwasi Torpey, MD, PhD, MPH Regional Senior Technical Advisor, FHI 8 th.
Use of routinely collected service delivery and M&E indicator data for timely feedback Denis Nash, PhD, MPH Associate Professor of Epidemiology Director,
Quality of Care at a Multi-site PEPFAR-funded ART Program: From Measuring to Improvement.
Unit 10. Monitoring and evaluation
ICAP Quarterly Master Slide Set April-June Site Census What: Ongoing, real-time inventory of all planned, current, and closed ICAP sites. Supported.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
Progress toward COP 12 targets Mozambique-ICB October
Data Specifications Didactics on development of a concept sheet EA IeDEA Meeting May 16-17, 2011 Beverly Musick.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Ministry of Health, Mozambique
Orientation on HIV care and ART Recording and Reporting System.
Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working.
ICAP Track 1.0 Year 6: Reaching Targets Focus on Quality Continued Innovations David Hoos, MD, MPH Dar es Salaam August 4, 2009.
Integrating PMTCT and ART N. Shaffer PMTCT/Peds TWG PEPFAR Track 1 Sept 25, 2007.
Implementing the revised TB/HIV indicators and data harmonisation at country level Christian Gunneberg MO WHO Planning workshop to accelerate the implementation.
Program data and standards of care to support transition planning in Mozambique M&E Tecnhical Meeting Johannesburg, South Africa July 29 th Maria Fernanda.
From Mekong to Bali: The scale up of TB/HIV collaborative activities in Asia- Pacific, August 8-9, 2009 Denpasar, Bali, Indonesia "TB/HIV Monitoring and.
Providing Treatment, Restoring Hope Program Updates Dr. Robb Sheneberger, MD University of Maryland School of Medicine Track 1.0 Implementers Meeting Dar.
Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.
President’s Emergency Plan for AIDS Relief 2006 Semi-Annual Program Results (SAPR) October 1, 2005 – March 31, 2006.
Data dissemination meeting February 28, 2007 ICAP New York.
Module 5: Monitoring Retention and Adherence to PMTCT and Planning the Way Forward.
Use of Routine Feedback Reports to Site and District Staff in Cote d’Ivoire Hermann Brou Annual Meeting, M&E satellite meeting Johannesburg, July 28, 2010.
Sub module 1 Introduction to HIV care and ART recording and reporting system.
EXTERNAL DQA METHODOLOGY AND IMPLEMENTATION ​ Mozambique Strategic Information Project (MSIP) ​ JSI Research & Training Institute, Inc. (JSI) in collaboration.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
From HIV Testing to Treatment: Operations Research to Improve ARV Treatment Programs Treatment Acceleration Program Meeting November 30, 2006 Mark Micek,
Visualizing data for program improvement with ICAP’s Unified Reporting System (URS): Presented by: Deborah Horowitz, Strategic Information Specialist,
Facility supervision by the District Health Teams (DHTs) in Rwanda Track1 Meeting Maputo, Mozambique, August 10 th -12 th Dr. Ruben Sahabo.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
ICAP Quarterly Master Slide Set July-September 2007.
Progress toward COP 12 targets DRC October
PMTCT - The Platform for integrating HIV/AIDS Services in the MCH Clinic. Bola Oyeledun, MD, MPH Track 1.0 Partners Meeting Washington DC. August 2008.
NFM: Modular Template Measurement Framework: Modules, Interventions and Indicators LFA M&E Training February
HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
1 Strengthening PMTCT Data Reporting and Use through Supportive Supervision and Routine Performance Evaluation: Experiences from Dedza and Ntcheu Districts,
Do Adolescents Equally Utilize PMTCT Services as Adult Women? Data from Patient Tracking Database in Zimbabwe 18 th ICASA, Harare 3 December 2015 Reuben.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Improving HIV care and support service performance in Côte d’Ivoire M. N’goran 1 ; S. Ramachadran 2 ; J. Essombo 1 et al M. N’goran 1 ; S. Ramachadran.
Evaluating the flow of adults in public HIV care systems in Mozambique: Identifying obstacles to care XVII International AIDS Conference August 5, 2008.
PMTCT PROGRAMME MONITORING DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
ADVANCING HIV NURSING PRACTICE IN THE COMMUNITY
Differentiated Monitoring & Evaluation
Dr. Kathure, Weyenga and Langat
Data Collection/Cleaning/Quality Processes MISAU Experience in Mozambique September 2017.
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Kenneth Sherr Embedded implementation science to enhance the relevance of effectiveness trials for structural interventions Kenneth Sherr.
Presentation transcript:

Utilizing Facility Data for Program Monitoring Valerie Koscelnik Track 1 ART Program Meeting Maputo, August 12, 2010

Outline Framework for health system components and outcomes Transition short & long term goal/objective Transition Logic model Measurements: –Site and Regional readiness –Outcome indicators Data quality assessments Summary and conclusions

Health Systems Building Blocks and Key Health Outcomes Overall Health Outcomes

Transition monitoring: What are we looking for? Long term goal & shorter-term objective Long term goal: sustained local ownership with maintenance of excellent patient care and good patient outcomes. Ultimately, a vision of an effective strengthened health systems. Shorter term objective: Sites and local partners (governmental and/or NGO) able to accept/absorb and grow the program with delivery of high quality care Source: Transition Logic Model Working Group

The Transition Logic Model: Inputs &Outputs individualized per partner Transition Logic Model Inputs and outputs individualized per partner

Process/Health System Measurements Site maturity: SCA-like tools Technical and organizational competency of local government and NGO partners Ownership – Performance & accountability documentation TBD Source: Transition Logic Model Working Group

Site readiness Kenya Locally developed site readiness tools assessing key domains ICAP-Kenya Track I Rapid Maturity Assessment Tool for Health Facility Transition: Assessed (1) services offered, (2) HR, (3) general management, (4) financial management, (5) quality management (6) procurement/supply chain management and (7) performance indicator: retention of patients in last 12 month Facility is ready for transition if scores 90% or greater Facilities below 90% require continued capacity building for transition

State and site readiness: Nigeria Structured assessment of state institutions and sites by (1) governance/leadership, (2) organizational structure, (3 & 4) HR & fin management, (5) external relationships, (6) service delivery, (7) pharmacy and (8) laboratory Scale used to determine priority states for transition

State Y

State X

Clinical Quality of Care Outcome indicators Adult care and treatment Pediatric care and treatment PMTCT TB/HIV Laboratory Counseling & Testing Adherence and Psychosocial support Need to focus on priority set of key Quality of Care indicators

ICAP priority quality indicators: Standards of Care (SOC) Rationale: Five priority quality indicators selected to allow for comparisons across sites, programs and countries* Creates a limited, manageable core set of indicators for program monitoring and review of quality Data sources: Routinely-collected site-level indicator data reported every quarter for HIV care and treatment (Track 1 reporting indicators), TB/HIV, and PMTCT programs Data imported from country aggregate databases or hand-entered on on-line indicator database Data checks are run on the data to ensure internal and cross-quarter consistency * Countries and site can select specific SOCs for monitoring & CQI activities

Program area Priority indicator Definition Care and Treatment 1 Eligible patients in care and treatment receive cotrimoxazole at enrollment and last visit 2 HIV infected children under one year of age receive ART 3 Patients enrolled into treatment remain in care for at least 6 months TB/HIV4 All patients in care and treatment receive TB screening at enrollment and during the quarter PMTCT5 HIV-infected pregnant women in PMTCT services receive multi-drug ARV prophylaxis Priority Quality Indicators

Priority Indicator 1 Target: 95% of eligible patients in care and treatment receive cotrimoxazole Aggregate data Measured byProportion of eligible patients in care and treatment receiving cotrimoxazole at enrollment NumeratorNumerator: Number of HIV-positive persons receiving cotrimoxazole prophylaxis DenominatorDenominator: Number of HIV-positive persons eligible to receive cotrimoxazole prophylaxis according to national guidelines To start centrally collecting in fall 2010

Priority Indicator 2 Target: 95% of HIV infected children under one year of age receive ART Aggregate data Measured byProportion infected children under one year of age receiving ART (Track 1 reporting) NumeratorNumber of patients <2 who were newly started on ART during the reporting quarter DenominatorNumber of patients <2 who were newly enrolled in care during the reporting quarter

Priority Indicator 3 Target: 90% of patients enrolled into treatment remain in care for at least 12 months Aggregate data Measured by Proportion of patients >6 years of age enrolled into treatment who received ARVs for 6 out of 6 months (Track 1 reporting) Numerator Number of ART patients >6 years of age who received ARVs for 6 out of 6 months Denominator Number of patients >6 years of age started on ART in a given 3 month period (e.g. for Oct-Dec reporting, Aug-Oct of year prior)

Priority Indicator 4 Target: 95% of all patients in care and treatment receive TB screening at enrollment Aggregate data Measured by Proportion of all patients in care and treatment receiving TB screening at enrollment Numerator All new HIV patients screened for TB at enrollment during the reporting quarter Denominator All new HIV patients enrolled in care during the reporting quarter

Priority Indicator 5 Target: 95% of HIV-infected pregnant women in PMTCT services receive multi-drug ARV prophylaxis Aggregate data Measured by Proportion of HIV-infected pregnant women in PMTCT services in ANC receiving multi-drug ARV prophylaxis Numerator Number of HIV positive pregnant women in ANC receiving multi-drug ARV prophylaxis including HAART during the reporting quarter Denominator Number of HIV positive pregnant women enrolled in ANC (known positive and tested positive) during the reporting quarter.

Indicators across country programs

Site specific trends in priority quality (SOC) indicators Mozambique

Site-specific trends in priority quality (SOC) indicators by site Rwanda

DQA Indicators Routinely Reported Indicator Data Source DQA Sample for Quarter of Interest Gold Standa rd DQA Indicator Denominat or DQA Indicator Numerator (completeness base on gold standard) % Eligible patients receiving CTX when enrolling in HIV care* Pre-ART Register Random sample Clinical File # in CTX eligible in DQA sample # with documented CTX % HIV+ children <1 yrs of age receiving ART* Pre-ART Register All Children <1 yrs Clinical File # in DQA sample # with documented ART start date % Patients enrolled in ART who remain in care for 6 of 6 months* ART Register Random sample from respective 6- mo cohort period Clinical File # in DQA sample # with documented visit 6 of 6 months % Patients in HIV care and treatment receiving TB screening at enrollment* Pre-ART Register Random sample Clinical File # in DQA sample # documented TB screening at enrollment % HIV+ pregnant women in PMTCT services receiving multi-drug prophylaxis* PMTCT Register All HIV+ pregnant women ANC Register # in DQA sample # with documentation of multi-drug prophylaxis * Quality Indicator

DQA Indicators (con’t) Routinely Reported Indicator Data Source DQA Sample for Quarter of Interest Gold StandardDQA Indicator Denominator DQA Indicator Numerator (completeness base on gold standard) # Patients currently on ART ART Register All patients on ART ART RegisterN/A# visiting ART clinic and receiving ARVs % Patients enrolled on ART for 6 months with a CD4 value ART Register Random sample from respective 6- mo cohort period Clinical File# in DQA sample # with documented CD4 count at 6 months % Patients screened for HIV when enrolling in TB services TB Register All new patients TB Register# in DQA sample # with documented HIV screening % Patients screen for HIV when enrolling in VCT or other POS VCT/PO S Register All new clientsVCT/POS Register # in DQA sample # with documented HIV screening

Summary Readiness assessments critical to determine status of health system components and provide important information for transition preparation and monitoring Quality indicator data at site and country levels provide critical outcome data on quality of health system outcomes before, during and after transition Data quality audits are important and can serve to monitor performance and could inform continued funding and accountability

Conclusions Data must always inform programs Data must continue to inform all aspects of transition efforts